| Date Filed | Type | Description |
| 08/14/2023 |
4
| Boston Megan (Executive Director) has filed a Form 4 on Benitec Biopharma Inc.|
Txns:
| Bought 25,907 shares
@ $0
Bought 25,907 options to buy
@ $3.86, valued at
$100k
|
|
| 08/14/2023 |
4
| BUCHI J KEVIN (Director) has filed a Form 4 on Benitec Biopharma Inc.|
Txns:
| Bought 51,813 shares
@ $0
Bought 51,813 options to buy
@ $3.86, valued at
$200k
|
|
| 12/09/2022 |
4
| Smith Edward F (Director) has filed a Form 4 on Benitec Biopharma Inc.|
Txns:
| Granted 12,000 options to buy
@ $0.1682, valued at
$2k
|
|
| 12/09/2022 |
4
| BUCHI J KEVIN (Director) has filed a Form 4 on Benitec Biopharma Inc.|
Txns:
| Granted 12,000 options to buy
@ $0.1682, valued at
$2k
|
|
| 12/09/2022 |
4
| Francis Peter (Director) has filed a Form 4 on Benitec Biopharma Inc.|
Txns:
| Granted 12,000 options to buy
@ $0.1682, valued at
$2k
|
|
| 12/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/10/2021 |
4
| Francis Peter (Director) has filed a Form 4 on Benitec Biopharma Inc.|
Txns:
| Granted 12,000 options to buy
@ $2.99, valued at
$35.9k
|
|
| 12/09/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/09/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 12/11/2020 |
4
| BUCHI J KEVIN (Director) has filed a Form 4 on Benitec Biopharma Inc.|
Txns:
| Granted 23,601 options to buy
@ $2.98, valued at
$70.3k
|
|
| 12/11/2020 |
4
| Francis Peter (Director) has filed a Form 4 on Benitec Biopharma Inc.|
Txns:
| Granted 23,601 options to buy
@ $2.98, valued at
$70.3k
|
|
| 12/11/2020 |
4
| Smith Edward F (Director) has filed a Form 4 on Benitec Biopharma Inc.|
Txns:
| Granted 23,601 options to buy
@ $2.98, valued at
$70.3k
|
|
| 12/11/2020 |
4
| Boston Megan (Executive Director) has filed a Form 4 on Benitec Biopharma Inc.|
Txns:
| Granted 142,172 options to buy
@ $2.98, valued at
$423.7k
|
|
| 12/11/2020 |
4
| Banks Jerel A. (CEO) has filed a Form 4 on Benitec Biopharma Inc.|
Txns:
| Granted 284,345 options to buy
@ $2.98, valued at
$847.3k
|
|
| 04/27/2020 |
3
| Nant Capital, LLC (10% Owner) has filed a Form 3 on Benitec Biopharma Inc. |
| 04/27/2020 |
3
| Banks Jerel A. (CEO) has filed a Form 3 on Benitec Biopharma Inc. |
| 04/27/2020 |
3
| Francis Peter (Director) has filed a Form 3 on Benitec Biopharma Inc. |
| 04/27/2020 |
3
| Smith Edward F (Director) has filed a Form 3 on Benitec Biopharma Inc. |
| 04/27/2020 |
3
| BUCHI J KEVIN (Director) has filed a Form 3 on Benitec Biopharma Inc. |
| 04/27/2020 |
3
| Boston Megan (Executive Director) has filed a Form 3 on Benitec Biopharma Inc. |